Literature DB >> 3558367

Structure and biological relationships of Coxiella burnetii lipopolysaccharides.

K Amano, J C Williams, S R Missler, V N Reinhold.   

Abstract

Lipopolysaccharides (LPSs) extracted from nine strains of Coxiella burnetii were analyzed for chemical compositions, molecular heterogeneity by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and lethal toxicities in galactosamine-sensitized mice. The structure of a unique disaccharide of hydrolyzed phase I LPS was determined to be galactosaminuronyl-alpha (1-6)-glucosamine (GalNU-alpha (1-6)-GlcN, C12H22N2O10) with an Mr of 354. The Mr of LPSs of C. burnetii intra- and interspecific strains and the content of GalNU-alpha (1-6)-GlcN and two sugars, virenose and dihydrohydroxystreptose, were used as biochemical markers of truncated LPSs. Smooth-phase I LPS contained all three compounds, semi-rough-phase I LPS did not contain virenose, and rough-phase II LPS contained none of the three compounds. These analyses indicate that the intermediate to larger Mr LPSs require the addition of GalNU-alpha (1-6)-GlcN and dihydrohydroxystreptose to obtain the major (10.5 kDa), the intermediate (between 10.5 and 27 kDa), and the minor (23 kDa) LPS bands. The addition of virenose to the major and the minor bands produced the large Mr phase I LPSs. Extreme microheterogeneity in the banding profile ranging in Mr from the 2.5 to 10.5 kDa may be due to unidentified components, while the microheterogeneity in Mr of the 10.5-kDa and larger LPS bands is related to variations in the compounds described here. All of the LPSs were toxic in galactosamine-sensitized mice, albeit they were 100-1000-fold less toxic than Escherichia coli and Salmonella typhimurium endotoxin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3558367

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Use of monoclonal antibodies to lipopolysaccharide for antigenic analysis of Coxiella burnetii.

Authors:  Akitoyo Hotta; Midori Kawamura; Ho To; Masako Andoh; Tsuyoshi Yamaguchi; Hideto Fukushi; Ken-Ichi Amano; Katsuya Hirai
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

2.  Phase variation analysis of Coxiella burnetii during serial passage in cell culture by use of monoclonal antibodies.

Authors:  Akitoyo Hotta; Midori Kawamura; Ho To; Masako Andoh; Tsuyoshi Yamaguchi; Hideto Fukushi; Katsuya Hirai
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

3.  The attenuated nine mile phase II clone 4/RSA439 strain of Coxiella burnetii is highly virulent for severe combined immunodeficient (SCID) mice.

Authors:  Aminul Islam; Michelle Lockhart; John Stenos; Stephen Graves
Journal:  Am J Trop Med Hyg       Date:  2013-08-19       Impact factor: 2.345

4.  alpha(v)beta(3) integrin and bacterial lipopolysaccharide are involved in Coxiella burnetii-stimulated production of tumor necrosis factor by human monocytes.

Authors:  J Dellacasagrande; E Ghigo; S M Hammami; R Toman; D Raoult; C Capo; J L Mege
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

5.  Refining the plasmid-encoded type IV secretion system substrate repertoire of Coxiella burnetii.

Authors:  Pauline Maturana; Joseph G Graham; Uma M Sharma; Daniel E Voth
Journal:  J Bacteriol       Date:  2013-05-17       Impact factor: 3.490

6.  Lipopolysaccharide phase variation determines the complement-mediated serum susceptibility of Coxiella burnetii.

Authors:  S Vishwanath; T Hackstadt
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

7.  Development of a lipopolysaccharide-targeted peptide mimic vaccine against Q fever.

Authors:  Ying Peng; Yan Zhang; William J Mitchell; Guoquan Zhang
Journal:  J Immunol       Date:  2012-10-10       Impact factor: 5.422

8.  Chemical properties of lipopolysaccharides from spotted fever group rickettsiae and their common antigenicity with lipopolysaccharides from Proteus species.

Authors:  K Amano; M Fujita; T Suto
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

9.  Serological studies of antigenic similarity between Japanese spotted fever rickettsiae and Weil-Felix test antigens.

Authors:  K Amano; H Hatakeyama; M Okuta; T Suto; F Mahara
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

10.  Genetic diversity of the Q fever agent, Coxiella burnetii, assessed by microarray-based whole-genome comparisons.

Authors:  Paul A Beare; James E Samuel; Dale Howe; Kimmo Virtaneva; Stephen F Porcella; Robert A Heinzen
Journal:  J Bacteriol       Date:  2006-04       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.